Charles Schwab Investment Management Inc Tricida, Inc. Transaction History

Charles Schwab Investment Management Inc

$429 Billion
Q1 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.14 - $12.49 $1,403 - $125,199	-10,024 Reduced 11.8%	74,893 $11,000
Q3 2022 Nov 14, 2022	SELL	$8.51 - $13.6 $32,108 - $51,312	-3,773 Reduced 4.25%	84,917 $890,000
Q2 2022 Aug 15, 2022	BUY	$7.31 - $11.85 $534,792 - $866,934	73,159 Added 471.05%	88,690 $859,000
Q4 2021 Feb 11, 2022	BUY	$4.19 - $9.56 $65,074 - $148,476	15,531 New	15,531 $149,000
Q3 2021 Nov 16, 2021	SELL	$3.56 - $4.64 $497,666 - $648,644	-139,794 Closed	0 $0

Q2 2021 Aug 16, 2021	SELL	$3.95 - $5.41 $191,448 - $262,211	-48,468 Reduced 25.74%	139,794 $604,000
Q1 2021 May 17, 2021	SELL	$4.52 - $7.8 $30,803 - $53,157	-6,815 Reduced 3.49%	188,262 $996,000
Q4 2020 Feb 16, 2021	BUY	$4.37 - $9.46 $26,875 - $58,179	6,150 Added 3.26%	195,077 $1.38 Million
Q3 2020 Nov 13, 2020	BUY	$8.56 - $26.93 $54,356 - $171,005	6,350 Added 3.48%	188,927 $1.71 Million
Q2 2020 Aug 14, 2020	BUY	$21.21 - $31.55 $512,497 - $762,342	24,163 Added 15.25%	182,577 $5.02 Million
Q1 2020 May 15, 2020	BUY	$18.43 - $38.04 $55,879 - $115,337	3,032 Added 1.95%	158,414 $3.49 Million
Q4 2019 Feb 07, 2020	BUY	$29.6 - $43.71 $117,216 - $173,091	3,960 Added 2.62%	155,382 $5.87 Million
Q3 2019 Nov 08, 2019	BUY	$29.87 - $42.22 $185,403 - $262,059	6,207 Added 4.27%	151,422 $4.68 Million
Q2 2019 Aug 09, 2019	BUY	$31.16 - $39.46 $1.59 Million - $2.02 Million	51,076 Added 54.26%	145,215 $5.73 Million
Q1 2019 May 14, 2019	BUY	$19.96 - $38.62 $315,248 - $609,964	15,794 Added 20.16%	94,139 $3.64 Million
Q4 2018 Feb 14, 2019	SELL	$23.57 - $32.33 $29,981 - $41,123	-1,272 Reduced 1.6%	78,345 $1.85 Million
Q3 2018 Nov 13, 2018	BUY	$22.5 - $39.35 $1.79 Million - $3.13 Million	79,617 New	79,617 $2.43 Million

Others Institutions Holding TCDA

# of Institutions

Shares Held

30K

Call Options Held

124K

Put Options Held

46.5K

View Full List

About Tricida, Inc.

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

More about TCDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account